Point72 Asset Management
MGNX icon

Point72 Asset Management’s MacroGenics MGNX Stock Holding History

Point72 Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$603K Sell
208,583
-40,574
-16% -$86.5K ﹤0.01% 3044
2025
Q4 		$401K Buy
+249,157
New +$392K ﹤0.01% 3351
2023
Q2 		– Sell
-540
Closed -$3.87K – 2532
2023
Q1 		$3.87K Buy
+540
New +$3.25K ﹤0.01% 2095
2022
Q1 		– Sell
-1,260,161
Closed -$20.2M – 1304
2021
Q4 		$20.2M Buy
1,260,161
+376,700
+43% +$7.09M 0.08% 335
2021
Q3 		$18.5M Buy
883,461
+470,361
+114% +$11.3M 0.08% 331
2021
Q2 		$11.1M Sell
413,100
-164,600
-28% -$4.82M 0.05% 424
2021
Q1 		$18.4M Sell
577,700
-882,433
-60% -$21.4M 0.09% 280
2020
Q4 		$33.4M Sell
1,460,133
-2,134,946
-59% -$49.2M 0.16% 173
2020
Q3 		$90.6M Buy
3,595,079
+2,234,949
+164% +$61M 0.46% 35
2020
Q2 		$38M Buy
1,360,130
+1,183,067
+668% +$20.6M 0.25% 106
2020
Q1 		$1.03M Buy
+177,063
New +$1.61M 0.01% 591
2019
Q4 		– Sell
-364,889
Closed -$4.66M – 1132
2019
Q3 		$4.66M Sell
364,889
-80,683
-18% -$1.16M 0.03% 470
2019
Q2 		$7.56M Sell
445,572
-1,105,677
-71% -$19M 0.04% 432
2019
Q1 		$27.9M Buy
1,551,249
+1,064,009
+218% +$18.4M 0.13% 190
2018
Q4 		$6.19M Sell
487,240
-647,177
-57% -$10.9M 0.03% 511
2018
Q3 		$24.3M Buy
1,134,417
+50,000
+5% +$1.07M 0.1% 253
2018
Q2 		$22.4M Hold
1,084,417
– – 0.09% 274
2018
Q1 		$27.3M Hold
1,084,417
– – 0.11% 230
2017
Q4 		$20.6M Sell
1,084,417
-96,900
-8% -$1.81M 0.09% 295
2017
Q3 		$21.8M Buy
1,181,317
+96,900
+9% +$1.68M 0.1% 250
2017
Q2 		$19M Sell
1,084,417
-96,400
-8% -$1.84M 0.11% 261
2017
Q1 		$22M Sell
1,180,817
-32,300
-3% -$623K 0.12% 228
2016
Q4 		$24.8M Sell
1,213,117
-600,183
-33% -$15.1M 0.17% 164
2016
Q3 		$54.2M Sell
1,813,300
-741,600
-29% -$22.1M 0.38% 56
2016
Q2 		$69M Buy
2,554,900
+224,700
+10% +$5.07M 0.47% 40
2016
Q1 		$43.7M Buy
2,330,200
+218,324
+10% +$4.16M 0.34% 71
2015
Q4 		$65.4M Sell
2,111,876
-418,824
-17% -$12.7M 0.54% 42
2015
Q3 		$54.2M Sell
2,530,700
-16,384
-0.6% -$514K 0.43% 59
2015
Q2 		$96.7M Buy
2,547,084
+196,133
+8% +$6.45M 0.67% 26
2015
Q1 		$73.7M Buy
2,350,951
+812,180
+53% +$27.5M 0.5% 38
2014
Q4 		$54M Buy
1,538,771
+17,671
+1% +$441K 0.38% 74
2014
Q3 		$31.8M Sell
1,521,100
-495,966
-25% -$10.3M 0.24% 116
2014
Q2 		$43.8M Buy
+2,017,066
New +$42.4M 0.28% 99

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Point72 Asset Management's MGNX Position: Q1 2026 in Review

Point72 Asset Management reduced its MacroGenics (MGNX) stake by 16% in Q1 2026, selling an estimated $86.5K and leaving 208,583 shares worth $603K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Point72 Asset Management first reported a position in MGNX in Q2 2014 and has held it in 33 quarters since. The position peaked at $96.7M in Q2 2015. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • Point72 Asset Management held 208,583 shares of MacroGenics worth $603K as of Q1 2026.
  • Point72 Asset Management sold 40,574 MacroGenics shares in Q1 2026, an estimated $86.5K.
  • MacroGenics made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3044 holding.
  • Point72 Asset Management first reported a position in MacroGenics in Q2 2014 and has held it in 33 quarters since.
  • Point72 Asset Management's MacroGenics position peaked at $96.7M in Q2 2015.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.